PT2721012T - Derivados do ácido biciclo(3.1.0)hexano-2,6¿dicarboxílico como agonista do recetor mglu2 - Google Patents

Derivados do ácido biciclo(3.1.0)hexano-2,6¿dicarboxílico como agonista do recetor mglu2

Info

Publication number
PT2721012T
PT2721012T PT127297695T PT12729769T PT2721012T PT 2721012 T PT2721012 T PT 2721012T PT 127297695 T PT127297695 T PT 127297695T PT 12729769 T PT12729769 T PT 12729769T PT 2721012 T PT2721012 T PT 2721012T
Authority
PT
Portugal
Prior art keywords
bicyclo
hexane
dicarboxylic acid
acid derivatives
receptor agonist
Prior art date
Application number
PT127297695T
Other languages
English (en)
Portuguese (pt)
Inventor
Tse Ki Man Teresa
Allen Monn James
Montero Salgado Carlos
Prieto Lourdes
Walton Lesley
Edward Tupper David
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PT2721012T publication Critical patent/PT2721012T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT127297695T 2011-06-17 2012-06-07 Derivados do ácido biciclo(3.1.0)hexano-2,6¿dicarboxílico como agonista do recetor mglu2 PT2721012T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11382208 2011-06-17
US201161522791P 2011-08-12 2011-08-12

Publications (1)

Publication Number Publication Date
PT2721012T true PT2721012T (pt) 2016-07-27

Family

ID=47357416

Family Applications (1)

Application Number Title Priority Date Filing Date
PT127297695T PT2721012T (pt) 2011-06-17 2012-06-07 Derivados do ácido biciclo(3.1.0)hexano-2,6¿dicarboxílico como agonista do recetor mglu2

Country Status (20)

Country Link
US (1) US9296710B2 (enExample)
EP (1) EP2721012B1 (enExample)
JP (1) JP5945592B2 (enExample)
KR (1) KR101598679B1 (enExample)
CN (1) CN103596933B (enExample)
AU (1) AU2012271024B2 (enExample)
BR (1) BR112013031928B1 (enExample)
CA (1) CA2836485C (enExample)
CY (1) CY1117682T1 (enExample)
DK (1) DK2721012T3 (enExample)
EA (1) EA023553B1 (enExample)
ES (1) ES2587204T3 (enExample)
HR (1) HRP20160676T1 (enExample)
HU (1) HUE030171T2 (enExample)
MX (1) MX2013014802A (enExample)
PL (1) PL2721012T3 (enExample)
PT (1) PT2721012T (enExample)
RS (1) RS54888B1 (enExample)
SI (1) SI2721012T1 (enExample)
WO (1) WO2012173850A1 (enExample)

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993006127A1 (en) 1991-09-17 1993-04-01 Warner-Lambert Company Novel amino acid prodrug renin inhibitors
US5576323A (en) 1993-12-03 1996-11-19 Eli Lilly And Company Excitatory amino acid receptor antagonists
US5849525A (en) 1994-03-09 1998-12-15 Brigham And Women's Hospital, Inc. Compositions corresponding to a proton-coupled peptide transporter and methods of making and using same
US5688826A (en) 1995-11-16 1997-11-18 Eli Lilly And Company Excitatory amino acid derivatives
CA2237910C (en) 1995-11-16 2005-12-27 Eli Lilly And Company Excitatory amino acid derivatives
GB9605429D0 (en) * 1995-11-16 1996-05-15 Lilly Co Eli Excitatory amino acid receptor antagonists
US5952294A (en) 1996-07-31 1999-09-14 University Of Pittsburgh Of The Commonwealth System Of Higher Education Peptidyl prodrugs and methods of making and using the same
ZA983930B (en) 1997-05-14 1999-11-08 Lilly Co Eli Excitatory amino acid receptor modulators.
WO1999038839A1 (en) 1998-01-28 1999-08-05 Taisho Pharmaceutical Co., Ltd. Fluorine-containing amino acid derivatives
CA2341865C (en) 1998-08-31 2006-01-17 Taisho Pharmaceutical Co., Ltd. 6-fluorobicyclo[3.1.0]hexane derivatives
US6716452B1 (en) 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
KR20030017562A (ko) 2000-06-28 2003-03-03 다이쇼 세이야꾸 가부시끼가이샤 신규 디카르복실산 유도체
US7256217B2 (en) 2001-01-11 2007-08-14 Eli Lilly And Company Prodrugs of excitatory amino acids
US7038077B2 (en) 2001-01-11 2006-05-02 Eli Lilly And Company Prodrugs of excitatory amino acids
WO2002068380A1 (en) * 2001-02-22 2002-09-06 Eli Lilly And Company Synthetic excitatory amino acids
US7067507B2 (en) 2001-06-12 2006-06-27 Pharmacia & Upjohn Company Macrocycles useful in the treatment of Alzheimer's disease
MXPA04006322A (es) 2001-12-27 2004-10-04 Taisho Pharmaceutical Co Ltd Derivados de 6-fluorobiciclo[3.1.0]hexano.
US20050192273A1 (en) 2002-04-03 2005-09-01 Johnson Bryan G. Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
EP1492595A1 (en) 2002-04-03 2005-01-05 Eli Lilly And Company Therapy for psychoses combining an atypical antipsychotic and an mglu2/3 receptor agonist
WO2003104217A2 (en) * 2002-06-01 2003-12-18 Eli Lilly And Company Prodrugs of excitatory amino acids
CN100482680C (zh) * 2002-06-11 2009-04-29 伊莱利利公司 兴奋性氨基酸前药
WO2005000790A1 (ja) * 2003-06-26 2005-01-06 Taisho Pharmaceutical Co., Ltd. 2-アミノビシクロ[3.1.0]ヘキサン-2,6-ジカルボン酸誘導体
ES2355144T3 (es) * 2003-06-26 2011-03-23 Taisho Pharmaceutical Co., Ltd. Derivado de éster 2-aminobiciclo 3.1.0 hexano-2,6-dicarboxílico.
US8735423B2 (en) * 2009-11-18 2014-05-27 Suven Life Sciences Limited Bicyclic compounds as α4β2 nicotinic acetylcholine receptor ligands
AR079343A1 (es) * 2009-12-21 2012-01-18 Lilly Co Eli Compuesto de acido 2-amino-4-(4h-1,2,4-triazol-3-ilsulfanil)biciclo[3.1.0]hexano-2,6-dicarboxilico, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para tratar un trastorno psiquiatrico

Also Published As

Publication number Publication date
HUE030171T2 (en) 2017-05-29
SI2721012T1 (sl) 2016-08-31
JP5945592B2 (ja) 2016-07-05
MX2013014802A (es) 2014-01-24
BR112013031928A2 (pt) 2016-12-13
CA2836485A1 (en) 2012-12-20
ES2587204T3 (es) 2016-10-21
KR101598679B1 (ko) 2016-02-29
KR20140009568A (ko) 2014-01-22
US20140113944A1 (en) 2014-04-24
CA2836485C (en) 2016-12-13
EA023553B1 (ru) 2016-06-30
RS54888B1 (sr) 2016-10-31
CY1117682T1 (el) 2017-05-17
CN103596933B (zh) 2016-03-23
EP2721012A1 (en) 2014-04-23
PL2721012T3 (pl) 2017-05-31
WO2012173850A1 (en) 2012-12-20
JP2014517035A (ja) 2014-07-17
DK2721012T3 (en) 2016-08-15
CN103596933A (zh) 2014-02-19
BR112013031928B1 (pt) 2022-05-24
EP2721012B1 (en) 2016-05-25
US9296710B2 (en) 2016-03-29
HRP20160676T1 (hr) 2016-07-15
AU2012271024B2 (en) 2015-07-09
AU2012271024A1 (en) 2013-11-21
EA201391700A1 (ru) 2014-04-30

Similar Documents

Publication Publication Date Title
ZA201903184B (en) Compositions, methods, and systems for the synthesis and use of imaging agents
TWI562994B (en) Fgf receptor (fgfr) agonist dimeric compounds, process for the preparation thereof and therapeutic use thereof
IL233325A0 (en) Dimeric compounds as an agonist for the fgfr (fgf) receptor, a process for their preparation and their therapeutic use
PL2635228T3 (pl) Aseptyczny dozownik
AU2012273365A8 (en) Glucagon/GLP-1 receptor co-agonists
GB201410398D0 (en) Muscarinic m1 receptor agonists
IT1404467B1 (it) Attrezzatura per il traino di biciclette, particolarmente per il traino di biciclette da bambino o simili
ZA201306229B (en) Substituted 4-aryl-n-phenyl-1,3,5-triazin-2- amines
SG2014005235A (en) Substituted 3-(biphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one
EP2617717A4 (en) ANTAGONIST OF P2X4 RECEIVER
EP2741751A4 (en) CONCENTRATED FELBAMATE FORMULATIONS FOR PARENTERAL ADMINISTRATION
EP2566494A4 (en) CXCR4 RECEPTOR COMPOUNDS
PT2748147T (pt) 2-alquilo-1-oxo-n-fenilo-3-heteroarilo-1,2,3,4 tetrahidroisoquinolina-4-carboxamidas substituídas para terapias antimaláricas
SI2721012T1 (sl) Derivati biciklo(3.1.0)heksan-2,6-dikarboksilne kisline kot agonisti mglu2 receptorja
CL2014001928A1 (es) Compuestos derivados de espiro[biciclo[3.1.0]hexano-4,1’-ciclopropano], agonistas del receptor mglu2/3; y composicion farmaceutica que los comprende.
GB201101693D0 (en) The LFA (Loop fed array) yagi
ES1075884Y (es) Estribera giratoria para monturas de equitación.
HK1193841A (en) Antagonists of the interleukin-1 receptor
HK1195913A (en) Glucagon/glp-1 receptor co-agonists
AU2011902551A0 (en) Hydrogen generator system for I.C.E
AU2011902769A0 (en) The ShuCati, Water Bike
GB201108297D0 (en) The stairwalker push chair
IL209042A0 (en) Face masks, face lotions, soaps with fruits
AU2011902599A0 (en) Attachment System for Composite Components
HK1190074A (en) Sustained release paracetamol formulations